Epitalon
Tetrapeptide studied primarily in Russian gerontology research for telomerase modulation and pineal function.
Educational only — not medical advice. SmartPeptide does not prescribe, diagnose, or treat. Always consult a licensed healthcare provider before using any peptide, supplement, medication, or protocol.
What the research shows
Small studies (mostly Russian gerontology programs) suggest effects on telomere biology and circadian/pineal markers in older adults. Some claim mortality benefit over multi-year follow-up.
What's still experimental
Independent replication outside of the original Russian research tradition is sparse. Western RCTs of meaningful size and duration are largely absent.
Anecdotal / community reports
Longevity-focused biohacker reports describe sleep and skin improvements; these are uncontrolled.
Anecdotal reports are NOT scientific evidence. They reflect personal experience and may not generalize.
FDA approval status
Source: openFDA + DailyMed (NIH/NLM)Doses studied in research
No established dose rangeWhat published trials tested or FDA-approved labels specify. Reporting research facts — not a SmartPeptide recommendation.
This is the honest answer for peptides like BPC-157, IGF-1 LR3, MOTS-c, Epitalon and similar research compounds — robust human dose- ranging studies have not been published. Always work with a licensed clinician familiar with experimental peptides if you are considering any use.
FDA enforcement & recalls
Live · openFDA Drug Enforcement APIMechanism & targets
ChEMBL · UniProt · Open TargetsProtein targets (UniProt)
- Telomerase reverse transcriptaseO14746gene: TERTHomo sapiens· 1132 aaReviewed
Telomerase is a ribonucleoprotein enzyme essential for the replication of chromosome termini in most eukaryotes. Active in progenitor and cancer cells. Inactive, or very low activity, in normal somatic cells. Catalytic component of the teleromerase holoenzyme complex whose main activity is the elongation of telomeres by acting as a reverse transcriptase that adds simple sequence repeats to chromosome ends by copying a template sequence within the RNA component of the enzyme. Catalyzes the RNA-de…
Live research
PubMed · ClinicalTrials.gov · Europe PMC · OpenAlexEurope PMC — 94 additional records
Includes EU/UK studies and PubMed Central full-text articles. Often surfaces research weeks before PubMed indexes it.
- LCP2 mediates SUV39H1-driven cellular senescence-related chemoresistance in natural killer/T-cell lymphomaZhang Y, Qian S, Yang Q, et al. · 2026
- Therapeutic peptides in gerontology: mechanisms and applications for healthy agingMavrych V, Shypilova I, Bolgova O., et al. · 2026Open access
- A State-of-the-Art Overview on (Epi)Genomics and Personalized Skin Rejuvenating StrategiesTauser RG, Vasincu IM, Iacob AT, et al. · 2025Open access
- Correction: Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activityAl-Dulaimi S, Thomas R, Matta S, et al. · 2025Open access
Research volume (OpenAlex topic graph)
Human clinical evidence
Semantic Scholar · AI TLDRs · influence-rankedHuman-study summaries for “epitalon” are available on Semantic Scholar but the shared free-tier API quota is exhausted right now. Try refreshing in a few minutes, or check the PubMed and Europe PMC panels above for the same literature.
Research funding & verification
NIH RePORTER · CrossRef DOI registryNIH-funded research
U.S. National Institutes of Health- 1Z01AG000288-03Proteins Implicated In Cardiac Senescence: Results FromKenneth R Boheler · NATIONAL INSTITUTE ON AGING · FY2002
- 1Z01AG000288-04Proteins Implicated In Cardiac SenescenceKenneth R Boheler · NATIONAL INSTITUTE ON AGING · FY2003
Publication landscape
CrossRef · DOI registry- NRF1 works
- International Atomic Energy Agency1 works
- IPEV1 works
- INTAROS1 works
- French Polar Institute1 works
- European Union—Next Generation EU—under the National Recovery and Resilience Plan1 works
Funder diversity is a credibility signal. Research concentrated in a single drug company's funding warrants more scrutiny than research funded across NIH, charities, and academic grants.
Preprints — cutting edge
bioRxiv · medRxiv · via Europe PMCPreprints have NOT been peer-reviewed. They are early research shared by authors before formal validation. Treat findings as preliminary.
- PreprintEpitalon increases telomere length in human cell lines through telomerase upregulation or ALT activityAl-dulaimi S, Thomas R, Matta S, et al. · 2025-07-15
Known risks
Most studies are small, single-center, and not independently replicated.
Reported side effects
No established safety profile in larger populations.
FDA adverse event reports (FAERS)
Updated quarterly by FDAWhat requires medical supervision
Not FDA-approved. Long-term safety in larger populations is uncharacterized.
Questions for your clinician
- What independent replications exist outside the original Russian work?
- What objective biomarkers (e.g., telomere length, biological-age clocks) would we measure?
- What's the rationale for cycling vs continuous use?